| Effect of co-infection with intestinal parasites on COVID-19 severity: a prospective observational cohort study D Wolday, T Gebrecherkos, ZG Arefaine, YK Kiros, A Gebreegzabher, ... EClinicalMedicine 39, 2021 | 102* | 2021 |
| Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia HE Abraha, Z Gessesse, T Gebrecherkos, Y Kebede, AW Weldegiargis, ... International Journal of Infectious Diseases 105, 776-783, 2021 | 74 | 2021 |
| Adherence to anti-tuberculosis treatment in Tigray, Northern Ethiopia YK Kiros, T Teklu, F Desalegn, M Tesfay, E Klinkenberg, A Mulugeta Public health action 4 (3), S31-S36, 2014 | 33 | 2014 |
| Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade D Wolday, Y Kebede, D Legesse, DS Siraj, JA McBride, MJ Kirsch, ... PloS one 15 (5), e0233049, 2020 | 28 | 2020 |
| The role of rk39 serologic test in the diagnosis of visceral leishmaniasis in a Tertiary Hospital, Northern Ethiopia YK Kiros, BF Regassa BMC research notes 10, 1-5, 2017 | 28 | 2017 |
| Performance of rapid rk39 tests for the diagnosis of visceral leishmaniasis in Ethiopia: a systematic review and meta-analysis DG Hagos, HDFH Schallig, YK Kiros, M Abdulkadir, D Wolday BMC Infectious Diseases 21, 1-11, 2021 | 25 | 2021 |
| Effect of co-infection with parasites on severity of COVID-19 T Gebrecherkos, Z Gessesse, Y Kebede, A Gebreegzabher, G Tasew, ... MedRxiv, 2021.02. 02.21250995, 2021 | 24 | 2021 |
| Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia D Wolday, D Legesse, Y Kebede, DS Siraj, JA McBride, R Striker PLoS One 15 (10), e0240880, 2020 | 23 | 2020 |
| Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub–Saharan Africa: A prospective longitudinal study T Gebrecherkos, YK Kiros, F Challa, S Abdella, A Gebreegzabher, D Leta, ... PLoS One 17 (3), e0263627, 2022 | 15 | 2022 |
| Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel YK Kiros, H Elinav, A Gebreyesus, H Gebremeskel, J Azar, D Chemtob, ... HIV medicine 20 (1), 33-37, 2019 | 8 | 2019 |
| Utility of the loop-mediated isothermal amplification assay for the diagnosis of visceral leishmaniasis from blood samples in Ethiopia DG Hagos, YK Kiros, M Abdulkader, ZG Arefaine, E Nigus, HHDF Schallig, ... The American Journal of Tropical Medicine and Hygiene 105 (4), 1050, 2021 | 7 | 2021 |
| Prognostic value of C-reactive protein in SARS-CoV-2 infection: A simplified biomarker of COVID-19 severity in Northern Ethiopia T Gebrecherkos, F Challa, G Tasew, Z Gessesse, Y Kiros, ... Infection and Drug Resistance, 3019-3028, 2023 | 6 | 2023 |
| Comparison of the diagnostic performances of five different tests in diagnosing visceral leishmaniasis in an endemic region of Ethiopia DG Hagos, YK Kiros, M Abdulkader, HDFH Schallig, D Wolday Diagnostics 14 (2), 163, 2024 | 4 | 2024 |
| Effect of rK39 testing in guiding treatment initiation and outcome in patients with visceral leishmaniasis in Ethiopia: A prospective cohort study DG Hagos, Y Kebede, M Abdulkader, E Nigus, Z Gessesse Arefaine, ... Plos one 16 (6), e0253303, 2021 | 4 | 2021 |
| Endoscopic and histopathological correlation of gastrointestinal diseases in ayder referral hospital, Mekelle University, Northern Ethiopia YK Kiros, B Tsegay, H Abreha Ethiopian Medical Journal 55 (4), 2017 | 4 | 2017 |
| SARS-CoV-2 antibody response among COVID-19 patients is not affected by parasite co-infection T Gebrecherkos, YK Kiros, F Challa, A Gebreegzabher, S Abdella, D Leta, ... medRxiv, 2023.08. 20.23294345, 2023 | | 2023 |
